5215-92-9Relevant articles and documents
-
Feuer,Kucera
, p. 5740 (1955)
-
MULTIVALENT RAS BINDING COMPOUNDS
-
Paragraph 00880, (2017/07/23)
Described herein are compounds that modulate Ras signaling, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with altered Ras signaling. Further described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds and methods of using such compounds in the treatment of cell proliferative disorders, including cancer.
Novel Enantiomeric Pure Beta Agonists, Manufacturing and Use as a Medicament Thereof
-
Page/Page column 8, (2008/06/13)
The present invention relates to enantiomerically pure compounds of formula 1 wherein the groups m, n, B, X, R1, m and Ym- may have the meanings given in the claims and specification, methods for preparing them and their use as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints.